This toolkit was put together to support practice facilitation partnerships with hospitals and community based health organizations of all sizes that serve people at-risk for or infected with hepatitis B or C. The toolkit offers multiple resources that can be used in various comb...
Publications
The new CDC algorithm for testing and treating pregnant women for hepatitis B The PHBPP Perinatal Algorithm has been finalized and is now posted on the Division of Viral Hepatitis webpage. The link is below: https://www.cdc.gov/hepatitis/hbv/perinatalxmtn.htm Here you will find...
In March 2020, the United States Preventive Services Task Force recommended one-time screening for hepatitis C in people aged 18-79. Simplified treatment guidance has been developed for hepatitis B and C.
Hep Free NYC is launching a capacity building initiative to support partners to implement hepatitis B and C telehealth services.
This report presents an overview of the NYC Health Department’s 2018 surveillance and research data on hepatitis B and C in NYC, as well as the Health Department’s programmatic activities to address these epidemics.
The Viral Hepatitis Program acknowledges that community testing programs are in a unique position to identify people at risk for hepatitis C, to provide testing and linkage to care. The following information is provided to support efficient community testing for programs that use...
This report presents an overview of the NYC Health Department’s 2017 surveillance and research data on hepatitis B and C in NYC, as well as the Health Department’s programmatic activities to address these epidemics.
We describe the mortality profile of NYC residents with HBV or HCV, emphasizing the contributions of HCC and HIV coinfection.
The NYC Department of Health and Mental Hygiene (DOHMH) examined anti-HCV and RNA testing performed by dialysis centres in NYC between 1 January 2014 and 31 December 2017 to assess HCV testing practices.
Evaluation of whether enrollment in Project INSPIRE was associated with differences in HCV treatment and cure compared with a demographically similar group not enrolled in the programme.
